PL2438920T3 - Preparaty kwetiapiny o kontrolowanym uwalnianiu - Google Patents

Preparaty kwetiapiny o kontrolowanym uwalnianiu

Info

Publication number
PL2438920T3
PL2438920T3 PL11184366T PL11184366T PL2438920T3 PL 2438920 T3 PL2438920 T3 PL 2438920T3 PL 11184366 T PL11184366 T PL 11184366T PL 11184366 T PL11184366 T PL 11184366T PL 2438920 T3 PL2438920 T3 PL 2438920T3
Authority
PL
Poland
Prior art keywords
quetiapine
controlled
release formulations
formulations
release
Prior art date
Application number
PL11184366T
Other languages
English (en)
Inventor
Ümit Cifter
Ali Türkyilmaz
Ediz Yildirim
Yelda Erdem
Ercan Ergenekon
Levent Öner
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43477967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2438920(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanovel Ilac Sanayi Ve Ticaret A.S. filed Critical Sanovel Ilac Sanayi Ve Ticaret A.S.
Publication of PL2438920T3 publication Critical patent/PL2438920T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11184366T 2010-10-08 2011-10-07 Preparaty kwetiapiny o kontrolowanym uwalnianiu PL2438920T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/08261A TR201008261A1 (tr) 2010-10-08 2010-10-08 Kontrollü salım gerçekleştiren ketiapin formülasyonları
EP11184366.0A EP2438920B1 (en) 2010-10-08 2011-10-07 Controlled-release formulations of quetiapine

Publications (1)

Publication Number Publication Date
PL2438920T3 true PL2438920T3 (pl) 2017-06-30

Family

ID=43477967

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11184366T PL2438920T3 (pl) 2010-10-08 2011-10-07 Preparaty kwetiapiny o kontrolowanym uwalnianiu

Country Status (4)

Country Link
EP (3) EP2438920B1 (pl)
ES (1) ES2608957T3 (pl)
PL (1) PL2438920T3 (pl)
TR (1) TR201008261A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11478483B2 (en) * 2017-09-08 2022-10-25 Cipla Limited Method of treating hypertension

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
GB9611328D0 (en) 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
WO2005041935A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
WO2006081347A2 (en) 2005-01-26 2006-08-03 Elan Pharma International Limited Controlled release compositions comprising an antipsychotic agent
CN101002737A (zh) 2005-09-26 2007-07-25 刘凤鸣 喹硫平的缓释制剂
PL2457563T3 (pl) 2006-05-09 2017-09-29 Mallinckrodt Llc Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego
PT103884A (pt) 2006-11-17 2008-05-19 Astrazeneca Ab Composições de libertação prolongada e métodos para a sua preparação
WO2009004480A2 (en) 2007-05-07 2009-01-08 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090220593A1 (en) * 2008-01-29 2009-09-03 Gulati Inder Extended release dosage forms of quetiapine
US20090264408A1 (en) * 2008-04-17 2009-10-22 Gulati Inder Extended release dosage forms of quetiapine
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
EP2153834A3 (en) * 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
WO2010089259A2 (en) * 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine

Also Published As

Publication number Publication date
ES2608957T3 (es) 2017-04-17
TR201008261A1 (tr) 2012-04-24
EP2438920B1 (en) 2016-09-28
EP3821894A1 (en) 2021-05-19
EP2438920A1 (en) 2012-04-11
EP3090747A1 (en) 2016-11-09
EP3090747B1 (en) 2020-12-09

Similar Documents

Publication Publication Date Title
PL2528602T5 (pl) Preparaty bendamustyny
SI2603232T1 (sl) Stabilne formulacije linaklotida
PL3178472T3 (pl) Doustne preparaty metylonaltreksonu
PL2442648T3 (pl) Preparaty neonikotynoidów niezawierające nmp
IL224192A (en) Compositions of Vitamin 14 – Epi Analogs d
EP2552210A4 (en) FORMULAS FROM MAZINDOL
ZA201300194B (en) Formulations
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
ZA201300196B (en) Formulations
GB201008470D0 (en) Formulations
GB201008358D0 (en) Formulations
GB201018649D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201012589D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201007702D0 (en) Formulations
GB201007959D0 (en) Formulations
GB201012047D0 (en) Pharmaceutical formulations
GB201012046D0 (en) Pharmaceutical formulations